ArticleBMC surgery2026
Comparison of short-term outcomes between laparoscopic transabdominal preperitoneal repair (TAPP) with biological mesh and laparoscopic intraperitoneal onlay mesh repair (IPOM Plus) with composite mesh for umbilical hernia.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo compare the short-term outcomes of laparoscopic transabdominal preperitoneal repair (TAPP) and laparoscopic intraperitoneal onlay mesh (IPOM Plus) repair for umbilical hernia.
methodsA retrospective analysis was conducted on 55 patients with umbilical hernia treated at the Second Affiliated Hospital of Xi’an Jiaotong University from July 2023 to March 2025. The patients were divided into two groups based on the surgical approach: the TAPP group (experimental group, n=30) and the IPOM Plus group (control group, n=25). Operation time, intraoperative blood loss, postoperative hospital stay, hernia recurrence, surgical site/mesh infection, seroma, foreign body sensation, postoperative pain, bowel obstruction and perforation were compared. Follow-ups were performed at 1, 3 and 6 months postoperatively.
resultsThere were no statistically significant differences between the two groups regarding baseline characteristics, intraoperative blood loss, postoperative hospital stay, recurrence rate, surgical site/mesh infection rate, seroma formation, bowel obstruction and perforation. However, the TAPP group demonstrated a longer operative time (P<0.05), while showing significantly lower postoperative pain scores and reduced incidence of foreign body sensation (P<0.05).
conclusionTAPP can significantly improve the patient's postoperative recovery experience. Although it prolongs operative time, its safety and short-term efficacy are comparable to IPOM Plus, providing an alternative surgical option for umbilical hernia repair. Further large-scale studies with long-term follow-up are needed to validate these advantages and establish TAPP as a routine surgical option for umbilical hernia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.